Synapse - Nursing

Results (38)

Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation

Journal Article

Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
Transplantation and Cellular Therapy (2024)

Fulltext@MSK | Save

Geriatric assessment and outcomes of allogeneic hematopoietic cell transplantation in older patients

Meeting Abstract

Dahi, P. B.; Shahrokni, A.; Flynn, J.; Devlin, S. M.; Chinapen, S. A.; Ayala, J.; Brown, S.; Bugen, S.; Cho, C.; Gyurkocza, B.; more...
Bone Marrow Transplantation (2023)

Fulltext@MSK | Save

Double unit cord blood transplantation compares favorably to T-cell depleted matched adult donor transplantation for the treatment of acute leukemia due to a robust protection against relapse

Meeting Abstract

Politikos, I.; Flynn, J.; Devlin, S. M.; Fingrut, W.; Maloy, M. A.; Naputo, K.; Chinapen, S.; Rodriguez, N. T.; Quach, S.; Dominguez, Y.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant

Journal Article

Sola, M.; Bhatt, V.; Palazzo, M.; Cavalier, K. E.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D.; Dahi, P. B.; more...
Bone Marrow Transplantation (2022)

Fulltext@MSK | Save

Characteristics and impact of post-transplant interdisciplinary palliative care consultation in older allogeneic hematopoietic cell transplant recipients

Journal Article

Lin, R. J.; Cohen, A. G.; Stabler, S. M.; Devlin, S. M.; Elko, T. A.; Maloy, M. A.; Korc-Grodzicki, B.; Alexander, K.; Kramer, D.; Sanchez-Escamilla, M.; more...
Journal of Palliative Medicine (2020)

Fulltext@MSK | Save

Efficacy of donor and 'third party' (Tabelecleucel) EBV-specific T cells for treatment of central nervous system (CNS) EBV-PTLD

Meeting Abstract

Prockop, S. E.; Suser, S.; Doubrovina, E. S.; Castro-Malaspina, H.; Papadopoulos, E. B.; Sauter, C. S.; Young, J. W.; Szenes, V.; Slocum, A.; Baroudy, K.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Adoptive therapy with EBV-specific T cells for treatment of CNS EBV post-transplant lymphoproliferative disease arising after hematopoietic stem cell transplant or solid organ transplant

Meeting Abstract

Prockop, S.; Suser, S.; Doubrovina, E.; Castro-Malaspina, H. R.; Papadopoulos, E. B.; Sauter, C. S.; Young, J. W.; Szenes, V.; Slocum, A.; Baroudy, K.; more...
Blood (2018)

Fulltext@MSK | Save

Effects of late toxicities on outcomes in long-term survivors of ex-vivo CD34(+)-selected allogeneic hematopoietic cell transplantation

Journal Article

Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant

Meeting Abstract

Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
Blood (2017)

Fulltext@MSK | Save

Five years of therapy with donor and 3rd party derived EBV and CMV specific cytotoxic T cells - Safety after more than 1,000 infusions

Meeting Abstract

Prockop, S.; Doubrovina, E.; Hasan, A.; Koehne, G.; Dahi, P.; Papadopoulos, E.; Sauter, C.; Rodriguez-Sanchez, I.; Suser, S.; Escobedo, V.; more...
Bone Marrow Transplantation (2017)

Fulltext@MSK | Save